SCHEMBL17078203

SCHEMBL17078203

C/C=C/C=C/C=C/C(=O)Oc1ccc(/C=C/c2cc(OC(=O)/C=C/C=C/C=C/C)cc(OC(=O)/C=C/C=C/C=C/C)c2)cc1

nearest known ligand 0.60

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KMT2A Q03164 5/20 0.60
▸ MEN1 O00255 3/20 0.60
▸ MAPT P10636 3/20 0.60
▸ TTR P02766 3/20 0.60
▸ KDM4E B2RXH2 2/20 0.60
▸ LMNA P02545 1/20 0.60
▸ TP53 P04637 1/20 0.60
▸ CYP3A4 P08684 1/20 0.60
▸ SMN1; SMN2 Q16637 1/20 0.60
▸ CYP19A1 P11511 2/20 0.49
▸ TUBB4A P04350 3/20 0.44
▸ TUBB P07437 3/20 0.44
▸ TUBA3C P0DPH7 3/20 0.44
▸ TUBA1B P68363 3/20 0.44
▸ TUBA4A P68366 3/20 0.44
▸ TUBB4B P68371 3/20 0.44
▸ TUBB3 Q13509 3/20 0.44
▸ TUBB2A Q13885 3/20 0.44
▸ TUBB8 Q3ZCM7 3/20 0.44
▸ TUBA3E Q6PEY2 3/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20394912 1.00 KMT2A (0.60) KMT2AMEN1MAPTTTRKDM4E
SCHEMBL2516279 0.98 KMT2A (0.62) KMT2AMEN1MAPTTTRKDM4E
SCHEMBL17078207 0.92 MEN1 (0.53) KMT2AMEN1MAPTTTRKDM4E
SCHEMBL2516228 0.92 KMT2A (0.58) KMT2AMEN1MAPTTTRKDM4E
SCHEMBL20394921 0.92 MEN1 (0.53) KMT2AMEN1MAPTTTRKDM4E
SCHEMBL18383806 0.90 KMT2A (0.56) KMT2AMEN1MAPTTTRKDM4E
SCHEMBL2520244 0.90 MEN1 (0.54) KMT2AMEN1MAPTTTRKDM4E
SCHEMBL2521524 0.88 KMT2A (0.57) KMT2AMEN1MAPTTTRKDM4E
SCHEMBL19873150 0.88 KMT2A (0.57) KMT2AMEN1MAPTTTRKDM4E
SCHEMBL18383810 0.87 PTGS2 (0.54) KMT2AMEN1MAPTTTRKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 15 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3116849-B1 COMPOUNDS WITH A COMBINED ANTIOXIDANT ACTIVITY AGAINST FREE RADICALS TOGETHER WITH AN ANTI-INFLAMMATORY ACTION, AND PHARMACEUTICAL AND COSMETIC COMPOSITIONS CONTAINING THEM FOR THE TREATMENT OF SKIN AND HAIR GIULIANI SPA (IT) 2018-07-25 — — EP claimed
US-9738682-B2 Compounds with a combined antioxidant activity against free radicals together with an anti-inflammatory action, and pharmaceutical and cosmetic compositions containing them for the treatment of skin and hair GIULIANI S.P.A. (IT) 2017-08-22 — — US claimed
US-20170015700-A1 COMPOUNDS WITH A COMBINED ANTIOXIDANT ACTIVITY AGAINST FREE RADICALS TOGETHER WITH AN ANTI-INFLAMMATORY ACTION, AND PHARMACEUTICAL AND COSMETIC COMPOSITIONS CONTAINING THEM FOR THE TREATMENT OF SKIN AND HAIR GIULIANI S.P.A. (IT) 2017-01-19 — — US claimed
EP-3116849-A1 COMPOUNDS WITH A COMBINED ANTIOXIDANT ACTIVITY AGAINST FREE RADICALS TOGETHER WITH AN ANTI-INFLAMMATORY ACTION, AND PHARMACEUTICAL AND COSMETIC COMPOSITIONS CONTAINING THEM FOR THE TREATMENT OF SKIN AND HAIR Giuliani S.p.A. (IT) 2017-01-18 — — EP claimed
WO-2015135927-A1 COMPOUNDS WITH A COMBINED ANTIOXIDANT ACTIVITY AGAINST FREE RADICALS TOGETHER WITH AN ANTI-INFLAMMATORY ACTION, AND PHARMACEUTICAL AND COSMETIC COMPOSITIONS CONTAINING THEM FOR THE TREATMENT OF SKIN AND HAIR GIULIANI S.P.A. (IT) 2015-09-17 — — WO claimed
EP-3116849-B1 COMPOUNDS WITH A COMBINED ANTIOXIDANT ACTIVITY AGAINST FREE RADICALS TOGETHER WITH AN ANTI-INFLAMMATORY ACTION, AND PHARMACEUTICAL AND COSMETIC COMPOSITIONS CONTAINING THEM FOR THE TREATMENT OF SKIN AND HAIR GIULIANI SPA (IT) 2018-07-25 — — EP disclosed
EP-3116849-B1 COMPOUNDS WITH A COMBINED ANTIOXIDANT ACTIVITY AGAINST FREE RADICALS TOGETHER WITH AN ANTI-INFLAMMATORY ACTION, AND PHARMACEUTICAL AND COSMETIC COMPOSITIONS CONTAINING THEM FOR THE TREATMENT OF SKIN AND HAIR GIULIANI SPA (IT) 2018-07-25 — — EP disclosed
US-9738682-B2 Compounds with a combined antioxidant activity against free radicals together with an anti-inflammatory action, and pharmaceutical and cosmetic compositions containing them for the treatment of skin and hair GIULIANI S.P.A. (IT) 2017-08-22 — — US disclosed
US-9738682-B2 Compounds with a combined antioxidant activity against free radicals together with an anti-inflammatory action, and pharmaceutical and cosmetic compositions containing them for the treatment of skin and hair GIULIANI S.P.A. (IT) 2017-08-22 — — US disclosed
US-9738682-B2 Compounds with a combined antioxidant activity against free radicals together with an anti-inflammatory action, and pharmaceutical and cosmetic compositions containing them for the treatment of skin and hair GIULIANI S.P.A. (IT) 2017-08-22 — — US disclosed
US-20170015700-A1 COMPOUNDS WITH A COMBINED ANTIOXIDANT ACTIVITY AGAINST FREE RADICALS TOGETHER WITH AN ANTI-INFLAMMATORY ACTION, AND PHARMACEUTICAL AND COSMETIC COMPOSITIONS CONTAINING THEM FOR THE TREATMENT OF SKIN AND HAIR GIULIANI S.P.A. (IT) 2017-01-19 — — US disclosed
US-20170015700-A1 COMPOUNDS WITH A COMBINED ANTIOXIDANT ACTIVITY AGAINST FREE RADICALS TOGETHER WITH AN ANTI-INFLAMMATORY ACTION, AND PHARMACEUTICAL AND COSMETIC COMPOSITIONS CONTAINING THEM FOR THE TREATMENT OF SKIN AND HAIR GIULIANI S.P.A. (IT) 2017-01-19 — — US disclosed
US-20170015700-A1 COMPOUNDS WITH A COMBINED ANTIOXIDANT ACTIVITY AGAINST FREE RADICALS TOGETHER WITH AN ANTI-INFLAMMATORY ACTION, AND PHARMACEUTICAL AND COSMETIC COMPOSITIONS CONTAINING THEM FOR THE TREATMENT OF SKIN AND HAIR GIULIANI S.P.A. (IT) 2017-01-19 — — US disclosed
EP-3116849-A1 COMPOUNDS WITH A COMBINED ANTIOXIDANT ACTIVITY AGAINST FREE RADICALS TOGETHER WITH AN ANTI-INFLAMMATORY ACTION, AND PHARMACEUTICAL AND COSMETIC COMPOSITIONS CONTAINING THEM FOR THE TREATMENT OF SKIN AND HAIR Giuliani S.p.A. (IT) 2017-01-18 — — EP disclosed
WO-2015135927-A1 COMPOUNDS WITH A COMBINED ANTIOXIDANT ACTIVITY AGAINST FREE RADICALS TOGETHER WITH AN ANTI-INFLAMMATORY ACTION, AND PHARMACEUTICAL AND COSMETIC COMPOSITIONS CONTAINING THEM FOR THE TREATMENT OF SKIN AND HAIR GIULIANI S.P.A. (IT) 2015-09-17 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170015700-A1 COMPOUNDS WITH A COMBINED ANTIOXIDANT ACTIVITY AGAINST FREE RADICALS TOGETHER WITH AN ANTI-INFLAMMATORY ACTION, AND PHARMACEUTICAL AND COSMETIC COMPOSITIONS CONTAINING THEM FOR THE TREATMENT OF SKIN AND HAIR ARG1, ARG2, TYR KMT2A 3121/4885MEN1 4365/4885MAPT 4337/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback